Stoneridge Investment Partners’s Bristol-Myers Squibb BMY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q4 | – | Sell |
-146,029
| Closed | -$7.56M | – | 142 |
|
|
2024
Q3 | $7.56M | Sell |
146,029
-1,544
| -1% | -$79.9K | 2.81% | 7 |
|
|
2024
Q2 | $6.13M | Buy |
147,573
+100,951
| +217% | +$4.19M | 2.32% | 10 |
|
|
2024
Q1 | $2.53M | Buy |
+46,622
| New | +$2.53M | 0.96% | 37 |
|
|
2022
Q1 | – | Sell |
-36,050
| Closed | -$2.25M | – | 107 |
|
|
2021
Q4 | $2.25M | Buy |
+36,050
| New | +$2.25M | 1.04% | 29 |
|
|
2021
Q3 | – | Sell |
-11,835
| Closed | -$791K | – | 114 |
|
|
2021
Q2 | $791K | Buy |
+11,835
| New | +$791K | 0.38% | 72 |
|
|
2021
Q1 | – | Sell |
-14,073
| Closed | -$873K | – | 113 |
|
|
2020
Q4 | $873K | Sell |
14,073
-10,852
| -44% | -$673K | 0.51% | 62 |
|
|
2020
Q3 | $1.5M | Buy |
+24,925
| New | +$1.5M | 0.99% | 32 |
|
|
2020
Q1 | – | Sell |
-22,457
| Closed | -$1.44M | – | 117 |
|
|
2019
Q4 | $1.44M | Sell |
22,457
-500
| -2% | -$32.1K | 0.49% | 66 |
|
|
2019
Q3 | $1.16M | Sell |
22,957
-86,310
| -79% | -$4.38M | 0.43% | 78 |
|
|
2019
Q2 | $4.96M | Buy |
+109,267
| New | +$4.96M | 1.76% | 13 |
|
|
2018
Q4 | – | Sell |
-43,681
| Closed | -$2.71M | – | 122 |
|
|
2018
Q3 | $2.71M | Sell |
43,681
-18,827
| -30% | -$1.17M | 0.58% | 64 |
|
|
2018
Q2 | $3.46M | Buy |
+62,508
| New | +$3.46M | 0.67% | 62 |
|
|
2017
Q2 | – | Sell |
-60,726
| Closed | -$3.3M | – | 261 |
|
|
2017
Q1 | $3.3M | Buy |
60,726
+54,557
| +884% | +$2.97M | 0.45% | 84 |
|
|
2016
Q4 | $361K | Sell |
6,169
-186,836
| -97% | -$10.9M | 0.05% | 237 |
|
|
2016
Q3 | $10.4M | Buy |
+193,005
| New | +$10.4M | 1.51% | 7 |
|